Article

Immune Reconstitution during Pneumocystis Lung Infection: Disruption of Surfactant Component Expression and Function by S-Nitrosylation

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
The Journal of Immunology (Impact Factor: 4.92). 02/2009; 182(4):2277-87. DOI: 10.4049/jimmunol.0802775
Source: PubMed

ABSTRACT

Pneumocystis pneumonia (PCP), the most common opportunistic pulmonary infection associated with HIV infection, is marked by impaired gas exchange and significant hypoxemia. Immune reconstitution disease (IRD) represents a syndrome of paradoxical respiratory failure in patients with active or recently treated PCP subjected to immune reconstitution. To model IRD, C57BL/6 mice were selectively depleted of CD4(+) T cells using mAb GK1.5. Following inoculation with Pneumocystis murina cysts, infection was allowed to progress for 2 wk, GK1.5 was withdrawn, and mice were followed for another 2 or 4 wk. Flow cytometry of spleen cells demonstrated recovery of CD4(+) cells to >65% of nondepleted controls. Lung tissue and bronchoalveolar lavage fluid harvested from IRD mice were analyzed in tandem with samples from CD4-depleted mice that manifested progressive PCP for 6 wks. Despite significantly decreased pathogen burdens, IRD mice had persistent parenchymal lung inflammation, increased bronchoalveolar lavage fluid cellularity, markedly impaired surfactant biophysical function, and decreased amounts of surfactant phospholipid and surfactant protein (SP)-B. Paradoxically, IRD mice also had substantial increases in the lung collectin SP-D, including significant amounts of an S-nitrosylated form. By native PAGE, formation of S-nitrosylated SP-D in vivo resulted in disruption of SP-D multimers. Bronchoalveolar lavage fluid from IRD mice selectively enhanced macrophage chemotaxis in vitro, an effect that was blocked by ascorbate treatment. We conclude that while PCP impairs pulmonary function and produces abnormalities in surfactant components and biophysics, these responses are exacerbated by IRD. This worsening of pulmonary inflammation, in response to persistent Pneumocystis Ags, is mediated by recruitment of effector cells modulated by S-nitrosylated SP-D.

Download full-text

Full-text

Available from: Elena N Atochina-Vasserman
  • Source
    • "Approximately 30 000 cells were then centrifuged onto a glass slide at 800 g for 3 min, air dried, and then stained with Diff-Quik buffered modified Wright- Giemsa stain. Cell differentials were performed manually using a light microscope at 40Â magnification (Atochina-Vasserman et al., 2009; Casey et al., 2005; Groves et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple studies have examined the direct cellular toxicity of silver nanoparticles (AgNPs). However, the lung is a complex biological system with multiple cell types and a lipid-rich surface fluid; therefore, organ level responses may not depend on direct cellular toxicity. We hypothesized that interaction with the lung lining is a critical determinant of organ level responses. Here, we have examined the effects of low dose intratracheal instillation of AgNPs (0.05 μg/g body weight) 20 and 110 nm diameter in size, and functionalized with citrate or polyvinylpyrrolidone. Both size and functionalization were significant factors in particle aggregation and lipid interaction in vitro. One day post-intratracheal instillation lung function was assessed, and bronchoalveolar lavage (BAL) and lung tissue collected. There were no signs of overt inflammation. There was no change in surfactant protein-B content in the BAL but there was loss of surfactant protein-D with polyvinylpyrrolidone (PVP)-stabilized particles. Mechanical impedance data demonstrated a significant increase in pulmonary elastance as compared to control, greatest with 110 nm PVP-stabilized particles. Seven days post-instillation of PVP-stabilized particles increased BAL cell counts, and reduced lung function was observed. These changes resolved by 21 days. Hence, AgNP-mediated alterations in the lung lining and mechanical function resolve by 21 days. Larger particles and PVP stabilization produce the largest disruptions. These studies demonstrate that low dose AgNPs elicit deficits in both mechanical and innate immune defense function, suggesting that organ level toxicity should be considered.
    Full-text · Article · Jul 2015 · Nanotoxicology
  • Source
    • "In an infection based murine model of lung inflammation we have demonstrated that CD4 + T cell immune-reconstituted (IRD) mice infected with Pneumocystis pneumonia (Pc) exhibit impaired pulmonary function with substantial increases in the BAL SP-D level [4]. Snitrosylation of SP-D and therefore alteration in SP-D higher order structure were markedly enhanced by immune-reconstitution during Pc infection. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Surfactant protein D (SP-D) is a member of the family of proteins termed collagen-like lectins or "collectins" that play a role in non-antibody-mediated innate immune responses [1]. The primary function of SP-D is the modulation of host defense and inflammation [2]. This review will discuss recent findings on the physiological importance of SP-D S-nitrosylation in biological systems and potential mechanisms that govern SP-D mediated signaling. SP-D appears to have both pro- and anti-inflammatory signaling functions. SP-D multimerization is a critical feature of its function and plays an important role in efficient innate host defense. Under baseline conditions, SP-D forms a multimer in which the N-termini are hidden in the center and the C-termini are on the surface. This multimeric form of SP-D is limited in its ability to activate inflammation. However, NO can modify key cysteine residues in the hydrophobic tail domain of SP-D resulting in a dissociation of SP-D multimers into trimers, exposing the S-nitrosylated N-termini. The exposed S-nitrosylated tail domain binds to the calreticulin/CD91 receptor complex and initiates a pro-inflammatory response through phosphorylation of p38 and NF-κB activation [3,4]. In addition, the disassembled SP-D loses its ability to block TLR4, which also results in activation of NF-κB. Recent studies have highlighted the capability of NO to modify SP-D through S-nitrosylation, causing the activation of a pro-inflammatory role for SP-D [3]. This represents a novel mechanism both for the regulation of SP-D function and NO's role in innate immunity, but also demonstrates that the S-nitrosylation can control protein function by regulating quaternary structure. This article is part of a Special Issue entitled Regulation of Cellular Processes by S-nitrosylation.
    Full-text · Article · Dec 2011 · Biochimica et Biophysica Acta
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nitric oxide (NO) is important for combating bacterial infections in the lungs. Levels of NO in the lungs are regulated by L-arginine, arginases (ARG) and NO synthases (NOS). Expression levels of ARG and inducible NOS (iNOS) vary among different types of macrophages (M0, M1, M2). Several events including infection, inflammation and tissue repair/resolution polarize macrophages (M0) into either M1 or M2 types. In general, M1 and M2 macrophages express high levels of iNOS and ARG, respectively. Classically activated M1 macrophages that are related to killing intracellular pathogens release T H 1 type cytokines (e.g., IFN, TNF, IL-1, IL-12) whereas the alternatively activated M2 macrophages that are involved in humoral immune response release T H 2 type cytokines (e.g., IL-4, IL-10). Based on the activating cytokines, M2 macrophages are further subdivided into M2a, M2b or M2c. Macrophage activation and polarization are also regulated by other soluble proteins such as the innate immune pattern-recognition collectins (collagenous lectins), surfactant protein (SP)-A and SP-D. These soluble defense molecules are known to recognize microbes, and agglutinate and/or form immune complexes to enhance pathogen clearance by macrophages. In the absence of SP-D, mouse alveolar macrophages show exaggerated M1-like phenotype. Certain microbial pathogens also modulate lung environment or macrophages to evade the nitric oxide-mediated immune response. In summary, interplay among microbes, cytokines, ARG, NOS and collectins regulate alveolar macrophage types and NO production in the lungs. The balance among these molecules appears to help eliminate microbial pathogens form the lungs with minimal inflammation.
    Full-text · Article · May 2010 · The Open Nitric Oxide Journal
Show more